Corvus Pharmaceuticals
CRVS
NZ$6.33
Share price
-3.50%
Change (1 day)
108.25%
Change (1 year)
Categories
Corvus Pharmaceuticals (CRVS) - Total liabilities
Total liabilities on the balance sheet as of March 2025 : NZ$16.59 Million
According to Corvus Pharmaceuticals 's latest financial reports the company's total liabilities are NZ$16.59 Million. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Corvus Pharmaceuticals - Total liabilities on balance sheet (from 2015 to 2025)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | NZ$10.86 M | -43.12% |
| 2022-12-31 | NZ$19.09 M | 6.11% |
| 2021-12-31 | NZ$17.99 M | -2.95% |
| 2020-12-31 | NZ$18.54 M | -0.36% |
| 2019-12-31 | NZ$18.61 M | 58.11% |
| 2018-12-31 | NZ$11.77 M | -15.89% |
| 2017-12-31 | NZ$13.99 M | 31.92% |
| 2016-12-31 | NZ$10.6 M | -94.4% |
| 2015-12-31 | NZ$0.18 B | 1068.97% |
| 2014-12-31 | NZ$16.19 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | NZ$37.93 M | 128.62% | 🇺🇸 USA |